Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Becton Dickinson saw its stock rise in pre-market trading after reporting fiscal Q3 2026 results that exceeded analyst expectations on both earnings and revenue, and after management raised its full-year adjusted EPS guidance. An analyst raised its price target while maintaining a Hold rating. The beat-and-raise quarter gave investors reassurance a…
Krispy Kreme Holdings reported Q2 2026 revenue of $331 million, topping analyst estimates of roughly $320.72 million, and produced a GAAP net loss of $19.8 million. The company logged a per-share loss of $0.03, missing the consensus for a $0.01 loss, and issued full-year 2026 revenue guidance of $1.25 billion to $1.35 billion, below the near $1.36 …
Shift4 Payments reported adjusted Q2 2026 earnings per share of $1.32 and adjusted revenue of $624 million, beating consensus estimates on both metrics. The stock plunged about 13.4% in pre-open trading as investors reacted to unchanged full-year guidance, modest adjusted free cash flow guidance for the quarter, and lingering leverage and internati…
Zoetis shares fell in pre-market trading after the company reported second-quarter 2026 results that narrowly beat EPS estimates but missed revenue expectations and issued full-year EPS guidance well below analyst consensus. Management also announced a combined CFO and COO appointment, contributing to investor unease as the stock approaches multi-y…
D-Wave Quantum Inc. reported second-quarter results that missed analyst expectations on both revenue and earnings per share, prompting a 10.5% decline in pre-market trading. Revenue for the quarter was $3.07 million versus consensus of $4.03 million, and EPS came in at ($0.13), short of the ($0.09) estimate. The company posted a narrower net loss y…
Howmet Aerospace rallied in pre-market trading after posting second-quarter 2026 results that exceeded analyst estimates across key metrics and prompted management to raise full-year guidance. The company reported Q2 EPS of $1.33 on $2.55 billion in revenue, delivered robust margin expansion and free cash flow, and now expects higher full-year earn…
Papa John’s stock fell sharply in pre-market trading after the pizza chain reported second-quarter 2026 results that narrowly exceeded analyst expectations on both earnings and revenue but still showed a meaningful year-over-year sales decline. The company also announced immediate leadership changes and continues to operate without a permanent chie…
Datadog shares fell sharply in pre-market trading after the company reported stronger-than-expected second-quarter results and lifted full-year guidance. The drop, driven largely by profit-taking following a substantial pre-earnings rally, came even though Datadog topped consensus on both revenue and earnings per share.
Sunrise Realty Trust, Inc. announced its Q2 2026 financial results, reporting a GAAP net income of $3.1 million and Distributable Earnings of $3.9 million. The company maintained all loans current, fully repaid a key investment, and paid a dividend of $0.30 per share, exceeding Distributable Earnings per share. The firm remains well-positioned with…
Unity Software's stock jumped 17% after the company reported a stronger-than-expected second quarter, with revenue and adjusted-profit metrics beating analyst estimates and management issuing a bullish revenue and adjusted EBITDA outlook for the third quarter. Strategic revenue, excluding certain business lines, showed particularly strong growth, w…
Constellation Energy Corp. stock surged 4.4% in pre-open trading after the company posted a second-quarter adjusted operating earnings beat and raised its fiscal 2026 outlook. Management also announced two board-level moves in the days ahead of the earnings release, reinforcing investor confidence despite recent analyst target cuts.
Insmed shares jumped 19.2% in pre-market trading after the company reported second-quarter 2026 results that outpaced analyst expectations on both revenue and EPS. Total revenue reached $425.5 million, led by Brinsupri sales of $309.2 million, and the company posted a near-breakeven net loss of $0.06 per share. Management raised full-year Brinsupri…
Fiserv's stock tumbled sharply in pre-market trading after the payments processor reported second-quarter results that missed expectations and issued weaker full-year guidance. Adjusted revenue and EPS declined year-over-year, management trimmed organic revenue and adjusted EPS forecasts for 2026, and investor concern has been amplified by recent l…
Hyliion Holdings will supply NAVSEA Philadelphia with two multi-megawatt KARNO Power Modules under a $41.7 million Office of Naval Research contract. The delivery expands naval testing and deployment of the company's modular architecture and pushes cumulative ONR support beyond $58 million, covering validation, testing, at-sea trials and now multi-…
Arcutis Biotherapeutics disclosed a routine equity divestment by its Executive Vice President and Chief Medical Officer, executed to cover tax withholding on vested restricted stock units. The transaction coincides with a period of accelerated financial performance, as the company recently reported a significant second-quarter revenue beat and offi…
Innoviva is facing genuine royalty roll-off concerns, but the stock's current valuation - roughly $1.52B market cap, P/E ~3, EV/EBITDA ~5.8 and an implied FCF yield near 12% - already factors in a dramatic earnings collapse. That makes a tactical long with defined risk-management attractive. This trade plan lays out entry, stop and layered targets …
NRG's recent LS Power acquisition (13 GW added) and raised FY26 guidance materially enlarge its generation footprint and optionality into data-center power. The numbers show upgraded EBITDA and FCF guidance, but the balance sheet and prior quarterly noise argue for an active, risk-managed long. This trade idea targets $150 with a $110 stop over a 1…
CT3 says its recently introduced Storage Contracts enabled rapid expansion of connected capacity to absorb higher volumes of user data after the rollout of an automatic backup service. To avoid excess idle capacity, the company will limit the sale of new contracts to the amount of storage that can be productively used, with some larger-capacity con…
ZenaTech, Inc., a Nasdaq-listed AI and drone technology company, announced the acquisition of Galena-Benchmark Engineering, a civil engineering and land surveying firm based in Idaho. This marks ZenaTech's 27th Drone as a Service acquisition, expanding its presence into its 13th U.S. state. The acquisition aims to broaden ZenaTech's service offerin…
InflaRx N.V. announced its second quarter 2026 financial results alongside key clinical and strategic updates. The company is advancing its oral C5aR inhibitor, izicopan, targeting ANCA-associated vasculitis (AAV) and select renal diseases, with Phase 2 clinical preparations ongoing. InflaRx is exploring regulatory strategies following the European…
Nayax Ltd., a Nasdaq-listed global commerce enablement and payments platform, has filed an application with the Connecticut Department of Banking to establish Nayax America Bank Inc., a non-depository innovation bank headquartered in Connecticut. The new bank, owned by Nayax USA Holdings, aims to offer embedded financial services such as corporate …
SAB Biotherapeutics reports Q2 2026 financial results highlighting progress in their SAB-142 immunotherapy for type 1 diabetes. The SAFEGUARD Phase 2b trial is on track with over 60 clinical sites activated and enrollment expected to complete by Q4 2026, with topline data anticipated in the second half of 2027. The company also secured a grant for …
Compass Therapeutics reported second quarter 2026 financial results and provided corporate updates, highlighting positive tovecimig Phase 2/3 data and expected FDA feedback this quarter. The company is advancing clinical trials for several bispecific antibody candidates targeting cancers, including expansions for CTX-8371 and initiation of CTX-471 …
Kelly Services, a specialty talent solutions provider listed on Nasdaq, announced its second-quarter 2026 results showing a 5.8% year-over-year revenue decline with improving trends across its Enterprise Talent Management (ETM) and Science, Engineering & Technology (SET) segments. Operating earnings were $16.1 million with adjusted EBITDA margin im…
Lexicon Pharmaceuticals completed enrollment for its pivotal Phase 3 SONATA-HCM study investigating sotagliflozin for hypertrophic cardiomyopathy, expects topline results in Q1 2027, and is nearing completion of NDA resubmission activities for ZYNQUISTA® in type 1 diabetes. The company also reported a net loss for Q2 2026 driven by increased R&D sp…
